Ozempic and Fertility: What to Know Before Trying to Conceive

Indirectly, and mostly through weight. Weight loss can restore ovulation in people whose cycles had stopped being regular, which is the mechanism behind the unplanned pregnancies these medicines have become known for.

That is not the drug improving fertility directly. It is a change in metabolic state producing a change in ovulation, which is the same reason lifestyle change sits first in the PCOS treatment ladder.

• Restored ovulation can happen without warning.
• Someone who assumed they could not conceive may now be able to.
• Severe nausea or vomiting can affect absorption of oral contraceptives.
• None of this makes the medicine a fertility treatment.

Our article on what actually changes the outcome in PCOS covers what the 2023 international guideline recommends for weight and ovulation.

Yes, and before conceiving rather than after. Guidance is that GLP-1 receptor agonists should be discontinued prior to pregnancy and that contraception should be used while taking them.

The reasoning is the state of the evidence rather than a demonstrated harm. Human data on use in pregnancy remain limited, and there is little for clinicians to draw on when counseling after accidental periconceptional exposure.

Animal studies are the reason for caution. In small animals exposed during pregnancy, adverse outcomes have included decreased fetal growth, skeletal and visceral anomalies and embryonic death. Animal findings do not transfer directly to humans, but with limited human data they carry more weight than they otherwise would.

The practical consequence is timing. Stopping needs to be planned around when you intend to conceive, which is a conversation to have before trying rather than during.

• Fertility Warning Signs: When Waiting Is the Wrong Move
• Endometriosis and IVF: What the Evidence Says About Surgery First
• Egg Quality and Age — What You Can Change, and What You Cannot (2026)
• Ayurveda and Fertility: What Has Actually Been Tested
• Antioxidants and Sperm Quality: What the Cochrane Review Found
• TSH and Fertility — What Your Thyroid Result Actually Means (India 2026)
• What Is Assisted Hatching — And Does the Evidence Support It? (2026)

Tell the prescribing clinician promptly, and expect an honest answer about uncertainty rather than a reassuring or alarming one. There are currently few data for clinicians to use in counseling after accidental periconceptional exposure.

Available human studies have not shown a higher fetal risk than insulin in the populations studied, which is reassuring as far as it goes. It is a limited evidence base and should be described that way.

• Do not stop other prescribed medicines without advice.
• Expect uncertainty to be acknowledged rather than resolved.
• Ask what monitoring, if any, is recommended.
• Exposure before a positive test is common and not a failure on your part.

This is where the interest is greatest, because PCOS is closely tied to insulin resistance and weight, and both affect ovulation. Restoring ovulation is the specific obstacle to conceiving in most PCOS.

The 2023 international PCOS guideline sets a lifestyle target of 5–10% weight loss where weight management is relevant, and recommends metformin alongside lifestyle at a BMI of 25 or above. GLP-1 medicines are not part of that fertility pathway.

• Letrozole remains first-line for ovulation induction in PCOS.
• Metformin is positioned for weight and metabolic management, not ovulation.
• GLP-1 medicines are not recommended as PCOS fertility treatment.
• Any weight-driven return of ovulation still requires stopping before conception.

So the sequencing matters more than it first appears. If a GLP-1 is being used for weight and the plan is to conceive, the medicine has to stop before the thing it helped bring about can safely happen.

These medicines have collected claims in both directions, and the confident ones are usually the least supported.

• They are not a fertility treatment and are not prescribed as one.
• They have not been shown to improve egg or sperm quality.
• They do not directly interfere with hormonal contraception.
• They are not established as safe in pregnancy — the data are limited, which is different.

The useful summary is short. Weight change can restore ovulation, so contraception matters while taking them; the medicine should be stopped before conceiving; and if conception happens first, that warrants a prompt conversation rather than panic.

What makes this genuinely difficult is that the medicine is often treating something that matters in its own right. Stopping is not free, and the decision involves weighing the condition being managed against the timing of a pregnancy — which is precisely why it belongs in a planned conversation rather than an urgent one after a positive test.

This area is also moving quickly. Guidance published today may be revised as human pregnancy data accumulate, so it is worth confirming current advice with the prescribing clinician rather than relying on an article, including this one.